Early-stage Breast Cancer Clinical Trial
Official title:
STACIE: Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted Therapy
This study proposes that the addition of statins reduces the treatment delays or early discontinuations secondary to cardiotoxicity in patients with Stage I-III HER2 positive breast being treated with anti-HER2 therapy.
A single arm open-label phase 2 study to evaluate the cardioprotective effects of statins in patients with Stage I-III HER2 positive breast cancer receiving HER2 targeted therapy. This study will evaluate the hypothesis that addition of statins will reduce treatment delays/discontinuations related to symptomatic/asymptomatic cardiac dysfunction in patients being treated with anti-HER2 therapy. The long-term goal of this study is to improve disease related outcomes and quality of life measures in patients being treated with anti-HER2 therapy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05528263 -
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
|
N/A | |
| Completed |
NCT00165243 -
Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer
|
Phase 2 | |
| Completed |
NCT03948568 -
Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)
|
Phase 4 | |
| Recruiting |
NCT04553770 -
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT06001762 -
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT03664687 -
Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)
|
Phase 4 | |
| Recruiting |
NCT04603209 -
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
|
||
| Completed |
NCT00233077 -
Patient Centered Randomized Controlled Trial
|
N/A | |
| Recruiting |
NCT02958033 -
Shandong Cancer Hospital Affiliated to Shandong University
|
Phase 3 | |
| Recruiting |
NCT03788083 -
Intratumoral TriMix Injections in Early Breast Cancer Patients
|
Phase 1 | |
| Recruiting |
NCT03797248 -
Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer
|
||
| Recruiting |
NCT05582499 -
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05871437 -
Huaier Granule on Reducing the Level of Tumor Markers in Patients With Early-stage Breast Cancer
|
Phase 4 | |
| Recruiting |
NCT04003558 -
Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)
|
||
| Terminated |
NCT03894007 -
Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT02982148 -
Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients
|
Phase 4 | |
| Active, not recruiting |
NCT03553797 -
Accelerated Whole Breast Irradiation Hypofractionation Plus Boost VS Standard Whole Breast Irradiation Plus Boost
|
Phase 3 | |
| Recruiting |
NCT06215469 -
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
|
N/A | |
| Enrolling by invitation |
NCT06409221 -
VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study
|
||
| Not yet recruiting |
NCT05280288 -
Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer
|
N/A |